Patents by Inventor Jon Durkin

Jon Durkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo[2,1-]-1,3,4-thiadiazole sulfonamides
    Patent number: 7772260
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: August 10, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt, H. Nicholas Marsh
  • Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamides
    Patent number: 7741349
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: April 5, 2006
    Date of Patent: June 22, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley Hewitt, H. Nicholas Marsh
  • Imidazo[2,1-]-1,3,4-thiadiazole sulfonamides
    Patent number: 7714003
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: May 11, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt
  • USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN
    Publication number: 20090170845
    Abstract: Disclosed herein are methods and compositions for treating and/or prophylaxis of neuropathic pain in a subject. The methods comprise administering to the subject suffering from neuropathic pain, a therapeutically effective amount of a compound, according to Formula I: or a salt thereof, wherein A, R5 and R6 are defined herein.
    Type: Application
    Filed: April 13, 2007
    Publication date: July 2, 2009
    Applicant: AEGERA THERAPEUTICS INC.
    Inventors: Jon Durkin, Kimberley Hewitt, Peter Winocour
  • IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES
    Publication number: 20090042953
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 7, 2008
    Publication date: February 12, 2009
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: James B. JAQUITH, Gerald VILLENEUVE, Alain BOUDREAULT, Stephen J. MORRIS, Jon DURKIN, John W. GILLARD, Kimberley E. HEWITT, H. Nicholas MARSH
  • Method of treating autoimmune diseases
    Publication number: 20080293653
    Abstract: The invention features a method of inducing an apoptosis-resistant cell to undergo apoptosis, in which the cell is associated with an autoimmune disease such as multiple sclerosis. The method involves sensitizing the cell to apoptosis stimuli by treating the cell with an IAP antisense oligonucleotide, so that the cell undergoes apoptosis at a site of autoimmune disease.
    Type: Application
    Filed: October 12, 2005
    Publication date: November 27, 2008
    Inventors: Jon Durkin, John Gillard, Trevor Owens, Stephen Morris, Simone Patricia Zehnter
  • Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
    Publication number: 20070265319
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: May 7, 2007
    Publication date: November 15, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: James Jaquith, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt
  • Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
    Publication number: 20070238768
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: May 7, 2007
    Publication date: October 11, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: James Jaquith, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt
  • Antisense IAP nucleobase oligomers and uses thereof
    Publication number: 20070135371
    Abstract: The present invention features nucleobase oligomers that hybridize to IAP polynucleotides, and methods for using them to enhance apoptosis.
    Type: Application
    Filed: October 26, 2006
    Publication date: June 14, 2007
    Inventors: Eric LaCasse, Daniel McManus, Jon Durkin, Robert Korneluk, Martin Holcik
  • Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides
    Patent number: 7230019
    Abstract: This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: June 12, 2007
    Assignee: Aegera Therapeutics, Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John W. Gillard, Kimberly Hewitt, H. Nicholas Marsh
  • Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
    Publication number: 20070088059
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 6, 2006
    Publication date: April 19, 2007
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
  • Antisense IAP nucleobase oligomers and uses thereof
    Publication number: 20070049544
    Abstract: The present invention features nucleobase oligomers that hybridize to IAP polynucleotide, and methods for using them to enhance apoptosis and treat proliferative disorders.
    Type: Application
    Filed: June 30, 2006
    Publication date: March 1, 2007
    Inventors: Eric LaCasse, Daniel McManus, Jon Durkin
  • Antisense IAP nucleobase oligomers and uses thereof
    Publication number: 20070032445
    Abstract: The present invention features nucleobase oligomers that hybridize to IAP polynuclotides, and methods for using them to enhance apoptosis and treat proliferative diseases.
    Type: Application
    Filed: May 30, 2006
    Publication date: February 8, 2007
    Inventors: Eric LaCasse, Daniel McManus, Jon Durkin
  • Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
    Publication number: 20070021416
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 6, 2006
    Publication date: January 25, 2007
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
  • Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
    Publication number: 20070021476
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 5, 2006
    Publication date: January 25, 2007
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
  • Methods and reagents for the treatment of proliferative diseases
    Publication number: 20050119217
    Abstract: The invention features methods, compositions, and kits for treating a patient having a proliferative disease.
    Type: Application
    Filed: October 28, 2004
    Publication date: June 2, 2005
    Inventors: Eric LaCasse, Daniel McManus, Jon Durkin
  • Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides
    Publication number: 20050069492
    Abstract: This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: December 16, 2002
    Publication date: March 31, 2005
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberly Hewitt, H. Marsh